Cited by 383Reproductive tract infections researchUrinary Tract Infections ManagementGynecological conditions and treatments

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis

Open access

Cohen, Craig R., Wierzbicki, Michael R., French, Audrey L., Morris, Sheldon, Newmann, Sara, Reno, Hilary, Green, Lauri, Miller, Steve, Powell, Jonathan, Parks, Thomas, Hemmerling, Anke·2020·New England Journal of Medicine

DOI 10.1056/nejmoa1915254PMC PMC7362958

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Bacterial vaginosis affects 15 to 50% of women of reproductive age, and recurrence is common after treatment with an antibiotic agent. The high incidence of recurrence suggests the need for new treatments to prevent recurrent bacterial vaginosis. METHODS: CTV-05 (Lactin-V) to prevent the recurrence of bacterial vaginosis. Women 18 to 45 years of age who had received a diagnosis of bacterial vaginosis and who had completed a course of vaginal metronidazole gel as part of the eligibility requirements were randomly assigned, in a 2:1 ratio, to receive vaginally administered Lactin-V or placebo for 11 weeks; follow-up occurred through week 24. The primary outcome was the percentage of women who had a recurrence of bacterial vaginosis by week 12. RESULTS: CTV-05 was detected in 79% of participants in the Lactin-V group. The percentage of participants who had at least one adverse event related to Lactin-V or placebo by week 24 did not differ significantly between the groups. The percentage of participants with local or systemic adverse events was similar in the two groups. CONCLUSIONS: The use of Lactin-V after treatment with vaginal metronidazole resulted in a significantly lower incidence of recurrence of bacterial vaginosis than placebo at 12 weeks. (Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT02766023.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1915254

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Inference and missing data
RUBIN, D. B. (1976) · Biometrika · doi:10.1093/biomet/63.3.581 · Cited by 9,925
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation
Nugent, R. P., Krohn, M. A., & Hillier, S. L. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.2.297-301.1991 · Cited by 3,332
Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.
Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., Kharsany, A. B. M., Sibeko, S., Mlisana, K. P., Omar, Z., et al. (2010) · Science · doi:10.1126/science.1193748 · Cited by 2,435
Nonspecific vaginitis
Amsel, R., Totten, P. A., Spiegel, C. A., Chen, K. C. S., Eschenbach, D. A., & Holmes, K. K. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91112-9 · Cited by 2,412
A Case–Control Study of Chorioamnionic Infection and Histologic Chorioamnionitis in Prematurity
Hillier, S. L., Martius, J., Krohn, M. A., Kiviat, N. B., Holmes, K. K., & Eschenbach, D. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810133191503 · Cited by 988
Vaginal Lactobacilli, Microbial Flora, and Risk of Human Immunodeficiency Virus Type 1 and Sexually Transmitted Disease Acquisition
Martin, H., Richardson, B. A., Nyange, P. M., Lavreys, L., Hillier, S. L., Chohan, B. H., Mandaliya, K. N., Ndinya‐Achola, J. O., Bwayo, J., & Kreiss, J. K. (1999) · The Journal of Infectious Diseases · doi:10.1086/315127 · Cited by 884
Cervicovaginal Bacteria Are a Major Modulator of Host Inflammatory Responses in the Female Genital Tract
Anahtar, M. N., Byrne, E. H., Doherty, K. E., Bowman, B. A., Yamamoto, H. S., Soumillon, M., Padavattan, N., Ismail, N., Moodley, A., Sabatini, M. E., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.019 · Cited by 814
High Recurrence Rates of Bacterial Vaginosis over the Course of 12 Months after Oral Metronidazole Therapy and Factors Associated with Recurrence
Bradshaw, C. S., Morton, A. N., Hocking, J. S., Garland, S. M., Morris, M. B., Moss, L. M., Horvath, L. B., Kuzevska, I., & Fairley, C. K. (2006) · The Journal of Infectious Diseases · doi:10.1086/503780 · Cited by 793
Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women
Gosmann, C., Anahtar, M. N., Handley, S. A., Farcasanu, M., Abu-Ali, G., Bowman, B. A., Padavattan, N., Desai, C., Droit, L., Moodley, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2016.12.013 · Cited by 696

Flagged first, then by citations

Show all 45 references

Sorted by citations

Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Self-citation
Emerging issues in probiotic safety: 2023 perspectives
Merenstein, D., Pot, B., Leyer, G., Ouwehand, A. C., Preidis, G. A., Elkins, C. A., Hill, C., Lewis, Z. T., Shane, A. L., Zmora, N., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2185034 · Cited by 481
The Female Vaginal Microbiome in Health and Bacterial Vaginosis
Chen, X. F., Lu, Y., Chen, T., & Li, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.631972 · Cited by 508
Towards a deeper understanding of the vaginal microbiota
France, M., Alizadeh, M. A., Brown, S. E., Ma, B., & Ravel, J. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01083-2 · Cited by 412
Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease
Ravel, J., Moreno, I., & Simón, C. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.10.019 · Cited by 375
Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring
Colbert, L. E., Alam, M. B. E., Wang, R., Karpinets, T. V., Lo, D., Lynn, E. J., Harris, T. A., Elnaggar, J. H., Yoshida-Court, K., Tomasic, K., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.09.012 · Cited by 286
A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation
Ma, Z., Zuo, T., Frey, N., & Rangrez, A. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01946-6 · Cited by 322
Update of probiotics in human world: A nonstop source of benefactions till the end of time
Zommiti, M., Feuilloley, M. G. J., & Connil, N. (2020) · Microorganisms · doi:10.3390/microorganisms8121907 · Cited by 225
Translocation of vaginal microbiota is involved in impairment and protection of uterine health
Wang, J., Li, Z., Ma, X., Du, L., Jia, Z., Cui, X., Yu, L., Yang, J., Xiao, L., Zhang, B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24516-8 · Cited by 197
The pregnancy microbiome and preterm birth
Bayar, E., Bennett, P. R., Chan, D., Sykes, L., & MacIntyre, D. A. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00817-w · Cited by 164
Vaginal microbiome-host interactions modeled in a human vagina-on-a-chip
Mahajan, G., Doherty, E. R., To, T., Sutherland, A. D., Grant, J. L., Junaid, A., Gulati, A., LoGrande, N., Izadifar, Z., Timilsina, S. S., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01400-1 · Cited by 152
Bacterial vaginosis: a review of approaches to treatment and prevention
Abbe, C., & Mitchell, C. M. (2023) · Frontiers in Reproductive Health · doi:10.3389/frph.2023.1100029 · Cited by 138
Bacterial vaginosis: drivers of recurrence and challenges and opportunities in partner treatment
Vodstrcil, L. A., Muzny, C. A., Plummer, E. L., Sobel, J. D., & Bradshaw, C. S. (2021) · BMC Medicine · doi:10.1186/s12916-021-02077-3 · Cited by 130
Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation
Bloom, S. M., Mafunda, N. A., Woolston, B. M., Hayward, M. R., Frempong, J. F., Abai, A. B., Xu, J., Mitchell, A. J., Westergaard, X. O., Hussain, F. A., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01070-7 · Cited by 114
Roles of the Microbiota of the Female Reproductive Tract in Gynecological and Reproductive Health
Zhu, B., Tao, Z., Edupuganti, L., Serrano, M. G., & Buck, G. A. (2022) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00181-21 · Cited by 131
Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression
Delgado-Diaz, D. J., Jesaveluk, B., Hayward, J. A., Tyssen, D. P., Alisoltani, A., Potgieter, M. G., Bell, L., Ross, E. J., Iranzadeh, A., Allali, I., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01337-5 · Cited by 126
The Vaginal Microbiome: A Long Urogenital Colonization Throughout Woman Life
Auriemma, R. S., Scairati, R., Vecchio, G. D., Liccardi, A., Verde, N., Pirchio, R., Pivonello, R., Ercolini, D., & Colao, A. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.686167 · Cited by 114
Use of probiotic lactobacilli in the treatment of vaginal infections: In vitro and in vivo investigations
Liu, P., Lu, Y., Li, R., & Chen, X. F. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1153894 · Cited by 122
Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis
Vodstrcil, L. A., Plummer, E. L., Fairley, C. K., Hocking, J. S., Law, M. G., Petoumenos, K., Bateson, D. J., Murray, G. L., Donovan, B. J., Chow, E. P. F., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2405404 · Cited by 113
Determinants of Vaginal Microbiota Composition
Moosa, Y., Kwon, D. S., de Oliveira, T., & Wong, E. B. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00467 · Cited by 112
Advances and future perspectives in epithelial drug delivery
Mohammed, Y., Holmes, A. M., Kwok, P. C. L., Kumeria, T., Namjoshi, S., Imran, M., Matteucci, L., Ali, M., Tai, W., Benson, H. A., et al. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114293 · Cited by 99
Antibiotic-free vaginal microbiota transplant with donor engraftment, dysbiosis resolution and live birth after recurrent pregnancy loss: a proof of concept case study
Wrønding, T., Vomstein, K., Bosma, E. F., Mortensen, B., Westh, H., Heintz, J. E., Mollerup, S., Petersen, A. M., Ensign, L. M., DeLong, K., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102070 · Cited by 99
The Complex Link between the Female Genital Microbiota, Genital Infections, and Inflammation
Dabee, S., Passmore, J.-A. S., Heffron, R., & Jaspan, H. B. (2021) · Infection and Immunity · doi:10.1128/iai.00487-20 · Cited by 89
Probiotics as Antibiotic Alternatives for Human and Animal Applications
Rabetafika, H. N., Razafindralambo, A., Ebenso, B., & Razafindralambo, H. L. (2023) · Encyclopedia · doi:10.3390/encyclopedia3020040 · Cited by 102
Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial
Armstrong, E., Hemmerling, A., Miller, S. A., Burke, K., Newmann, S. J., Morris, S., Reno, H., Huibner, S., Kulikova, M., Nagelkerke, N. J. D., et al. (2022) · The Lancet Microbe · doi:10.1016/s2666-5247(22)00043-x · Cited by 81
Self-citation
Direct on-swab metabolic profiling of vaginal microbiome host interactions during pregnancy and preterm birth
Pruski, P., Correia, G. D. S., Lewis, H., Capuccini, K., Inglese, P., Chan, D., Brown, R. G., Kindinger, L. M., Lee, Y. S., Smith, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26215-w · Cited by 80
Female reproductive tract-organ axes
Takada, K., Melnikov, V. G., Kobayashi, R., Komine‐Aizawa, S., Tsuji, N. M., & Hayakawa, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1110001 · Cited by 84
The right bug in the right place: opportunities for bacterial vaginosis treatment
Wu, S., Hugerth, L. W., Schuppe‐Koistinen, I., & Du, J. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00295-y · Cited by 78
The Role of Antimicrobial Resistance in Refractory and Recurrent Bacterial Vaginosis and Current Recommendations for Treatment
Muzny, C. A., & Sobel, J. D. (2022) · Antibiotics · doi:10.3390/antibiotics11040500 · Cited by 71
Probiotics are a good choice for the treatment of bacterial vaginosis: a meta-analysis of randomized controlled trial
Chen, R., Li, R., Wei, Q., Zhang, Y., Zhou, Z., Hou, Y., Shi, Y., Zhou, H., & Chen, M. (2022) · Reproductive Health · doi:10.1186/s12978-022-01449-z · Cited by 75
The endometrial microbiota and early pregnancy loss
Odendaal, J., Black, N., Bennett, P. R., Brosens, J. J., Quenby, S. M., & MacIntyre, D. A. (2023) · Human Reproduction · doi:10.1093/humrep/dead274 · Cited by 76
Finding a Balance in the Vaginal Microbiome: How Do We Treat and Prevent the Occurrence of Bacterial Vaginosis?
Joseph, R. J., Ser, H.-L., Kuai, Y.-H., Tan, L. T.-H., Arasoo, V. J. T., Letchumanan, V., Wang, L., Pusparajah, P., Goh, B.-H., Ab Mutalib, N.-S., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10060719 · Cited by 68
Bacterial vaginosis
Bradshaw, C. S., Plummer, E. L., Muzny, C. A., Mitchell, C. M., Fredricks, D. N., Herbst‐Kralovetz, M. M., & Vodstrcil, L. A. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00626-1 · Cited by 72
Evaluation and Management of Vaginitis
Marnach, M. L., Wygant, J. N., & Casey, P. M. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.09.022 · Cited by 64
The urinary microbiome and biological therapeutics: Novel therapies for urinary tract infections
Kenneally, C., Murphy, C. P., Sleator, R. D., & Culligan, E. P. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127010 · Cited by 69
Vaginal Lactobacillus fatty acid response mechanisms reveal a metabolite-targeted strategy for bacterial vaginosis treatment
Zhu, M., Frank, M. W., Radka, C. D., Jeanfavre, S., Xu, J., Tse, M. W., Pacheco, J. A., Kim, J. S., Pierce, K., Deik, A., et al. (2024) · Cell · doi:10.1016/j.cell.2024.07.029 · Cited by 61
Diagnosis and Management of Bacterial Vaginosis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines
Muzny, C. A., Balkus, J. E., Mitchell, C. M., Sobel, J. D., Workowski, K., Marrazzo, J. M., & Schwebke, J. R. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac021 · Cited by 61
Animal Models and Alternatives in Vaginal Research: a Comparative Review
McCracken, J. M., Calderon, G. A., Robinson, A., Sullivan, C. N., Cosgriff‐Hernandez, E., & Hakim, J. C.-E. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00529-y · Cited by 58
Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis
Mtshali, A., San, J. E., Osman, F., Garrett, N., Balle, C., Giandhari, J., Onywera, H., Mngomezulu, K., Mzobe, G. F., de Oliveira, T., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.730986 · Cited by 57
Modeling the temporal dynamics of cervicovaginal microbiota identifies targets that may promote reproductive health
Munoz, A. R., Hayward, M. R., Bloom, S. M., Rocafort, M., Ngcapu, S., Mafunda, N. A., Xu, J., Xulu, N., Dong, M., Dong, K. L., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01096-9 · Cited by 52
Beyond bacterial vaginosis: vaginal lactobacilli and HIV risk
Armstrong, E., & Kaul, R. (2021) · Microbiome · doi:10.1186/s40168-021-01183-x · Cited by 66
Recent Advances in Presentation, Diagnosis and Treatment for Mixed Vaginitis
Qi, W., Li, H., Wang, C., Li, H., Zhang, B., Dong, M., Fan, A., Han, C., & Xue, F. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.759795 · Cited by 62
Lactobacilli biology, applications and host interactions
Mejía-Caballero, A., & Marco, M. L. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01205-7 · Cited by 65
Screening and characterization of vaginal fluid donations for vaginal microbiota transplantation
Yockey, L. J., Hussain, F. A., Bergerat, A., Reissis, A., Worrall, D. P., Xu, J., Gomez, I., Bloom, S. M., Mafunda, N. A., Kelly, J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-22873-y · Cited by 53
Recent advances in understanding of multifaceted changes in the vaginal microenvironment: implications in vaginal health and therapeutics
Das, S., Bhattacharjee, M. J., Mukherjee, A. K., & Khan, M. R. (2023) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2049696 · Cited by 51
Probiotic Lactobacillus sp. Strains Inhibit Growth, Adhesion, Biofilm Formation, and Gene Expression of Bacterial Vaginosis-Inducing Gardnerella vaginalis
Qian, Z., Zhu, H., Zhao, D., Yang, P., Gao, F., Lu, C., Yin, Y., Kan, S., & Chen, D. (2021) · Microorganisms · doi:10.3390/microorganisms9040728 · Cited by 51
Bacterial Vaginosis and Behavioral Factors Associated With Incident Pelvic Inflammatory Disease in the Longitudinal Study of Vaginal Flora
Turpin, R., Tuddenham, S., He, X., Klebanoff, M. A., Ghanem, K. G., & Brotman, R. M. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab103 · Cited by 49
Novel Selective Inhibition of Lactobacillus iners by Lactobacillus -Derived Bacteriocins
Nilsen, T., Swedek, I., Lagenaur, L. A., & Parks, T. (2020) · Applied and Environmental Microbiology · doi:10.1128/aem.01594-20 · Cited by 51
Self-citation
Protection and Risk: Male and Female Genital Microbiota and Sexually Transmitted Infections
Tuddenham, S., Ravel, J., & Marrazzo, J. M. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa762 · Cited by 51
Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections
Avitabile, E., Menotti, L., Croatti, V., Giordani, B., Parolin, C., & Vitali, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179168 · Cited by 51
Recent advances in therapeutic probiotics: insights from human trials
Cho, M.-Y., Eom, J.-H., Choi, E.-M., Yang, S., Lee, D., Kim, Y.-Y., Kim, H.-S., & Hwang, I. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00240-24 · Cited by 53
Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis–associated bacteria rather than lactobacilli
Armstrong, E., Hemmerling, A., Miller, S., Burke, K. E., Newmann, S. J., Morris, S. R., Reno, H., Huibner, S., Kulikova, M., Liu, R., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci152930 · Cited by 47
Self-citation
Connecting the Dots: Translating the Vaginal Microbiome Into a Drug
Lagenaur, L. A., Hemmerling, A., Chiu, C. Y., Miller, S. A., Lee, P. P., Cohen, C. R., & Parks, T. P. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa676 · Cited by 45
Self-citation
Bacterial vaginosis: A state of microbial dysbiosis
Mondal, A. S., Sharma, R., & Trivedi, N. (2023) · Medicine in Microecology · doi:10.1016/j.medmic.2023.100082 · Cited by 44
Vaginal dysbiosis and the potential of vaginal microbiome-directed therapeutics
Valeriano, V. D., Lahtinen, E., Hwang, I., Zhang, Y., Du, J., & Schuppe‐Koistinen, I. (2024) · Frontiers in Microbiomes · doi:10.3389/frmbi.2024.1363089 · Cited by 49
Connecting microbiome and menopause for healthy ageing
Łaniewski, P., & Herbst‐Kralovetz, M. M. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01071-6 · Cited by 42
Abrupt perturbation and delayed recovery of the vaginal ecosystem following childbirth
Costello, E. K., DiGiulio, D. B., Robaczewska, A., Symul, L., Wong, R. J., Shaw, G. M., Stevenson, D. K., Holmes, S., Kwon, D. S., & Relman, D. A. (2023) · Nature Communications · doi:10.1038/s41467-023-39849-9 · Cited by 41
Diversity in women and their vaginal microbiota
Condori-Catachura, S., Ahannach, S., Ticlla, M., Kenfack, J. M., Esemu, L. F., Anukam, K. C., Pinedo-Cancino, V., Collado, M. C., Domínguez-Bello, M. G., Miller, C. B., et al. (2025) · Trends in Microbiology · doi:10.1016/j.tim.2024.12.012 · Cited by 49
Recurrent Bacterial Vaginosis: An Unmet Therapeutic Challenge. Experience With a Combination Pharmacotherapy Long-Term Suppressive Regimen
Surapaneni, S., Akins, R. A., & Sobel, J. D. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001420 · Cited by 41
Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial
Hemmerling, A., Mitchell, C. M., Demby, S. M., Ghebremichael, M. S., Elsherbini, J., Xu, J., Xulu, N., Shih, J. B., Dong, K. L., Govender, V., et al. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2024.101037 · Cited by 38
Self-citation
Probiotic Lacticaseibacillus rhamnosus GR-1 and Limosilactobacillus reuteri RC-14 as an Adjunctive Treatment for Bacterial Vaginosis Do Not Increase the Cure Rate in a Chinese Cohort: A Prospective, Parallel‐Group, Randomized, Controlled Study
Zhang, Y., Lyu, J., Ge, L., Huang, L.-T., Peng, Z., Liang, Y., Zhang, X., & Fan, S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.669901 · Cited by 40
Impact of (recurrent) bacterial vaginosis on quality of life and the need for accessible alternative treatments
Chow, K., Wooten, D. A., Annepally, S., Burke, L., Edi, R., & Morris, S. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02236-z · Cited by 39
Self-citation
Oral administration of Lactobacillus crispatus M247 to papillomavirus-infected women: results of a preliminary, uncontrolled, open trial
Pierro, F. D., Criscuolo, A. A., Giudici, A. D., Senatori, R., Sesti, F., Ciotti, M., & Piccione, E. (2021) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.21.04752-7 · Cited by 39
Probiotic lactobacilli in formulas and hygiene products for the health of the urogenital tract
Nader-Macı́as, M. E., Gregorio, P. R. D., & Silva, J. A. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.787 · Cited by 42
Urinary Tract Infection and Microbiome
Kim, D. S., & Lee, J. W. (2023) · Diagnostics · doi:10.3390/diagnostics13111921 · Cited by 38
The microbial revolution: Unveiling the benefits of vaginal probiotics and prebiotics
Pagar, R. R., Deshkar, S. S., Mahore, J., Patole, V., Deshpande, H., Gandham, N. R., MIRZA, S. B., Junnarkar, M. V., & Nawani, N. N. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127787 · Cited by 39
Impact of a multi-strain L. crispatus-based vaginal synbiotic on the vaginal microbiome: a randomized placebo-controlled trial
Ravel, J., Simmons, S. L., Greenwood, E. A., Gottfried, S., Greene, M., Kellogg‐Spadt, S., Gevers, D., & Harper, D. M. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00788-6 · Cited by 35
Orally administrated Lactobacillus gasseri TM13 and Lactobacillus crispatus LG55 can restore the vaginal health of patients recovering from bacterial vaginosis
Qi, F., Fan, S., Fang, C., Ge, L., Lyu, J., Huang, Z., Zhao, S., Zou, Y., Huang, L.-T., Liu, X., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1125239 · Cited by 40
Safety, tolerability, and acceptability of Lactobacillus crispatus CTV-05 (LACTIN-V) in pregnant women at high-risk of preterm birth
Bayar, E., MacIntyre, D. A., Sykes, L., Mountain, K. E., Lee, Y., Parks, T., Lee, P. P., & Bennett, P. R. (2023) · Beneficial Microbes · doi:10.3920/bm2022.0084 · Cited by 33
Self-citation
The Female Reproductive Tract Microbiota: Friends and Foe
Kumar, L., Dwivedi, M., Jain, N., Shete, P., Solanki, S. S., Gupta, R. K., & Jain, A. (2023) · Life · doi:10.3390/life13061313 · Cited by 35
Genital tract microbiota composition profiles and use of prebiotics and probiotics in gynaecological cancer prevention: review of the current evidence, the European Society of Gynaecological Oncology prevention committee statement
Mitra, A., Gültekin, M., Ellis, L. B., Bizzarri, N., Bowden, S. J., Taumberger, N., Bracic, T., Vieira‐Baptista, P., Sehouli, J., & Kyrgiou, M. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00257-4 · Cited by 36
Sex is associated with the persistence of non‐optimal vaginal microbiota following treatment for bacterial vaginosis: a prospective cohort study
Ratten, L. K., Plummer, E. L., Murray, G. L., Danielewski, J., Fairley, C. K., Garland, S. M., Hocking, J. S., Tachedjian, G., Chow, E., Bradshaw, C. S., et al. (2020) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16430 · Cited by 33
Rapid-dissolving electrospun nanofibers for intra-vaginal antibiotic or probiotic delivery
Minooei, F., Gilbert, N. M., Zhang, L., NeCamp, S. M., Mahmoud, M. Y., Kyser, A. J., Tyo, K. M., Watson, W. H., Patwardhan, R., Lewis, W. G., et al. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.07.009 · Cited by 32
Understanding and Preventing Recurring Bacterial Vaginosis: Important Considerations for Clinicians
Muzny, C. A., & Sobel, J. D. (2023) · International Journal of Women s Health · doi:10.2147/ijwh.s383333 · Cited by 33
Bioinspired approaches to encapsulate and deliver bacterial live biotherapeutic products
Brittain, N. Y., & Finbloom, J. A. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115663 · Cited by 34
Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism
Cheu, R. K., Gustin, A. T., Lee, C. Y., Schifanella, L., Miller, C. J., Ha, A., Kim, C., Rodriguez, V. J., Fischl, M. A., Burgener, A., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009024 · Cited by 32
Postbiotic gel relieves clinical symptoms of bacterial vaginitis by regulating the vaginal microbiota
Shen, X., Xu, L. H., Zhang, Z., Yang, Y., Li, P., Ma, T., Guo, S., Kwok, L., & Sun, Z. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1114364 · Cited by 38
Bacterial adhesion strategies and countermeasures in urinary tract infection
Flores, C., & Rohn, J. L. (2025) · Nature Microbiology · doi:10.1038/s41564-025-01926-8 · Cited by 31
Living Therapeutics: The Next Frontier of Precision Medicine
Kelly, V. W., Liang, B. K., & Sirk, S. J. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00444 · Cited by 30
Fabrication and characterization of bioprints with Lactobacillus crispatus for vaginal application
Kyser, A. J., Masigol, M., Mahmoud, M. Y., Ryan, M., Lewis, W. G., Lewis, A. L., Frieboes, H. B., & Steinbach-Rankins, J. M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.023 · Cited by 31
The reproductive tract microbiota in pregnancy
Grewal, K. J., MacIntyre, D. A., & Bennett, P. R. (2021) · Bioscience Reports · doi:10.1042/bsr20203908 · Cited by 31
Deciphering the role of female reproductive tract microbiome in reproductive health: a review
Gao, H., Liu, Q., Wang, X., Li, T., Li, H., Li, G., Tan, L., & Chen, Y. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1351540 · Cited by 34
The Female Reproductive Tract Microbiome—Implications for Gynecologic Cancers and Personalized Medicine
Rizzo, A. E., Gordon, J., Berard, A. R., Burgener, A., & Avril, S. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060546 · Cited by 30
Probiotics, a promising therapy to reduce the recurrence of bacterial vaginosis in women? a systematic review and meta-analysis of randomized controlled trials
Chieng, W. K., Jalal, M. I. A., Bedi, J. S., Zainuddin, A. A., Mokhtar, M. H., Abu, M. A., Chew, K. T., & Azurah, A. G. N. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.938838 · Cited by 33
The Vaginal Microbiome: V. Therapeutic Modalities of Vaginal Microbiome Engineering and Research Challenges
Vieira-Baptista, P., Seta, F. D., Verstraelen, H., Ventolini, G., Lonnee-Hoffmann, R., & Lev-Sagie, A. (2021) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000647 · Cited by 29
VagiBIOM Lactobacillus suppository improves vaginal health index in perimenopausal women with bacterial vaginosis: a randomized control trial
Vivekanandan, V., Khan, Z. H., Venugopal, G., Musunuru, B., Mishra, P. P., Srivastava, S., Ramadass, B., & Subhadra, B. G. (2024) · Scientific Reports · doi:10.1038/s41598-024-53770-1 · Cited by 30
Design of probiotic delivery systems and their therapeutic effects on targeted tissues
Xu, C., Guo, J., Chang, B., Zhang, Y., Tan, Z., Tian, Z., Duan, X., Ma, J., Jiang, Z., & Hou, J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.08.037 · Cited by 32
Evaluation of vulvovaginitis in the adolescent patient
Itriyeva, K. (2020) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2020.100836 · Cited by 34
Lactic acid gel versus metronidazole for recurrent bacterial vaginosis in women aged 16 years and over: the VITA RCT
Armstrong-Buisseret, L., Brittain, C., Kai, J., David, M. D., Watkins, J. A., Ozolins, M., Jackson, L., Abdali, Z., Hepburn, T., Griffiths, F., et al. (2022) · Health Technology Assessment · doi:10.3310/zzkh4176 · Cited by 28
Strain-level variation among vaginal Lactobacillus crispatus and Lactobacillus iners as identified by comparative metagenomics
Nori, S. R. C., Walsh, C. J., McAuliffe, F. M., Moore, R. L., Van Sinderen, D., Feehily, C., & Cotter, P. D. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00682-1 · Cited by 29
Non- Lactobacillus -Dominant and Polymicrobial Vaginal Microbiomes Are More Common in Younger South African Women and Predictive of Increased Risk of Human Immunodeficiency Virus Acquisition
Wang, Y., Noël‐Romas, L., Perner, M., Knodel, S., Molatlhegi, R. P., Hoger, S., Birse, K., Zuend, C. F., McKinnon, L. R., & Burgener, A. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac938 · Cited by 29
Vaginal microbiome in obesity and its impact on reproduction
Garg, A., Ellis, L. B., Love, R. L., Grewal, K. J., Bowden, S. J., Bennett, P. R., & Kyrgiou, M. (2023) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2023.102365 · Cited by 29
Harnessing the power within: engineering the microbiome for enhanced gynecologic health
Brennan, C., Chan, K., Kumar, T., Maissy, E. S., Brubaker, L. T., Dothard, M. I., Gilbert, J. A., Gilbert, K. E., Lewis, A. L., Thackray, V. G., et al. (2024) · Reproduction and Fertility · doi:10.1530/raf-23-0060 · Cited by 29
Microbial regulators of physiological and reproductive health in women of reproductive age: their local, proximal and distal regulatory roles
Cheng, Q., Lv, S., Yin, N., & Wang, J. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00839-y · Cited by 31
A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis
Schwebke, J. R., Carter, B. A., Waldbaum, A. S., Agnew, K. J., Paull, J. R., Price, C. F., Castellarnau, A., McCloud, P., & Kinghorn, G. R. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology X · doi:10.1016/j.eurox.2021.100121 · Cited by 26
Population-level analyses identify host and environmental variables influencing the vaginal microbiome
Qin, L., Sun, T., Li, X., Zhao, S., Liu, Z., Zhang, C., Jin, C., Xu, Y., Cao, Y., Cao, Y., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02152-8 · Cited by 28
Cervicovaginal Microbiome: Physiology, Age-Related Changes, and Protective Role Against Human Papillomavirus Infection
Alizhan, D., Ukybassova, T., Bapayeva, G., Aimagambetova, G. N., Kongrtay, K., Kamzayeva, N., & Terzić, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051521 · Cited by 30
Self-Interference Digital Optofluidic Genotyping for Integrated and Automated Label-Free Pathogen Detection
Zhou, T., Fu, R., Hou, J., Yang, F., Chai, F., Mao, Z., Deng, A., Li, F., Guan, Y., Hu, H., et al. (2024) · ACS Sensors · doi:10.1021/acssensors.4c01520 · Cited by 24
Vaginal and Penile Microbiome Associations With Herpes Simplex Virus Type 2 in Women and Their Male Sex Partners
Mehta, S. D., Nandi, D., Agingu, W., Green, S. J., Bhaumik, D. K., Bailey, R. C., & Otieno, F. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa529 · Cited by 26
Sexual transmission of urogenital bacteria: whole metagenome sequencing evidence from a sexual network study
Carter, K. A., France, M., Rutt, L., Bilski, L., Martinez-Greiwe, S., Regan, M. B., Brotman, R. M., & Ravel, J. (2024) · mSphere · doi:10.1128/msphere.00030-24 · Cited by 24

Authors: Cohen, C. R., Wierzbicki, M. R., French, A. L., Morris, S., Newmann, S., Reno, H., Green, L., Miller, S., Powell, J., Parks, T., & Hemmerling, A.
Affiliations: University of California, San Francisco (US)
Rush University Medical Center (US)
ORCID: Cohen, Craig R.
French, Audrey L.
Newmann, Sara
Reno, Hilary
Green, Lauri
Miller, Steve
Parks, Thomas
Hemmerling, Anke
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2020-05-14
Volume: 382
Issue: 20
Pages: 1906-1915
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1915254
PMC: PMC7362958
OpenAlex: W3024851520
Cited by: 377
References: 45
Citations by year: 2026: 71 · 2025: 70 · 2024: 55 · 2023: 60 · 2022: 47 · 2021: 52 · 2020: 22
FWCI: 33.29
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.nejmgroup.org/legal/terms-of-use.htm (vor)
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institute of Allergy and Infectious Diseases (HHSN272201300014I/HHSN27200007)
Topics: Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
Health Sciences › Medicine › Urology › Urinary Tract Infections Management
Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords: bacterial vaginosis, recurrence prevention, vaginal probiotics, Lactobacillus, metronidazole, vaginal treatment, adverse events
MeSH terms: Lactobacillus crispatus, Administration, Intravaginal, Adolescent, Adult, Antibiosis, Anti-Bacterial Agents, Double-Blind Method, Female, Gels, Humans, Metronidazole, Middle Aged, Vagina, Incidence, Vaginosis, Bacterial, Secondary Prevention, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks